Inflammatory Breast Cancer
📧 Sign up to get email alerts when something new happens for Inflammatory Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluates carboplatin and paclitaxel with or without panitumumab in invasive triple-negative breast cancer. The stu…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer [Phase 2]
A Phase 2 clinical trial studying whether adding Olaparib to radiation therapy improves outcomes for inflammatory breast cancer; the study i…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer [NA]
This ClinicalTrials.gov entry describes an ongoing study evaluating brain MRI screening in patients with breast cancer, including HER2-posit…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating neratinib and paclitaxel with or without pertuzumab and trastuzumab before combination chemotherapy in metastatic…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Onvansertib + Paclitaxel In TNBC [Phase 1, Phase 2]
This document reports an ongoing Phase 1/2 clinical trial evaluating the combination of onvansertib with paclitaxel in patients with triple-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy [Phase 2]
Phase 2 trial evaluating pembrolizumab in hormone receptor-positive, localized inflammatory breast cancer patients on hormone therapy who di…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer [Phase 3]
A Phase 3 trial update reports results for patient preference regarding home administration of a subcutaneous fixed-dose combination of pert…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Refining Local-Regional Therapy for IBC [NA]
A Dana-Farber Cancer Institute–led clinical trial is refining local-regional therapy for inflammatory breast cancer and is currently recruit…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating a combination of atezolizumab, cobimetinib, and eribulin in chemotherapy-resistant metastatic inflammatory…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma [NA]
A clinical trial evaluating whether lymphovenous bypass performed before axillary lymph node surgery can reduce the risk of lymphedema in pa…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Multi-center MRD Registry for Inflammatory Breast Cancer
A multi-center registry study evaluating minimal residual disease in inflammatory breast cancer, currently recruiting at MD Anderson Cancer …
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: TRUDI: TDXD+Durva in HER2+/Low IBC [Phase 2]
Phase 2 trial TRUDI is evaluating trastuzumab deruxtecan (TDXd) plus durvalumab (Durva) in HER2-positive and HER2-low invasive and inflammat…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating immunotherapy in combination with chemotherapy for HER2-negative inflammatory breast cancer; the st…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy [Phase 2]
This Phase 2 clinical trial update evaluates pembrolizumab in patients with stage IV inflammatory breast cancer or triple-negative breast ca…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer [Phase 1, Phase 2]
This document reports a Phase 1/2 trial of grapiprant plus eribulin for metastatic inflammatory breast cancer, which was terminated and whos…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test [Phase 1, Phase 2]
A Phase Ib/II trial evaluating neratinib plus capmatinib in metastatic breast cancer and inflammatory breast cancer with abnormal HER-family…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating an omega-3 fatty acid-based anti-cancer therapy in patients with metastatic triple-negative inflammato…
-
CLINICAL_TRIALS withdrawal · 2024-05-10Clinical Trial Update: Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study [NA]
A feasibility study evaluating hypnosis for pain in Black women with advanced breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer [Phase 2]
Phase 2 trial evaluating ruxolitinib in combination with preoperative chemotherapy for triple-negative inflammatory breast cancer; the study…
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients [Phase 2, Phase 3]
A Phase 2/Phase 3 trial investigates weekly paclitaxel and cisplatin for various breast cancer subtypes, including hormone receptor positive…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer [Phase 2]
Phase 2 trial update of pertuzumab plus trastuzumab and nab-paclitaxel (albumin-stabilized nanoparticle paclitaxel) for HER2-positive advanc…
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating accelerated radiation therapy after surgery for breast cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer [Phase 2]
A Phase 2 trial exploring pre-surgical treatment with carboplatin and an albumin-stabilized nanoparticle formulation of paclitaxel in patien…
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial of talimogene laherparepvec for recurrent breast cancer that cannot be removed surgically has been terminated; result…
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer [Phase 2]
Phase 2 trial evaluating eribulin followed by the AC chemotherapy regimen as preoperative therapy for HER2-negative inflammatory breast canc…